Main legislative changes in healthcare system in Bulgaria during 1997-2012
| dc.contributor.author | Marcheva, M. | |
| dc.contributor.author | Tosheva-Konteva, L. | |
| dc.contributor.author | Petrova, G. | |
| dc.date.accessioned | 2015-08-07T12:13:24Z | |
| dc.date.available | 2015-08-07T12:13:24Z | |
| dc.date.issued | 2013-09 | |
| dc.description | Address for correspondence: Prof. Dr. G. Petrova; Faculty of Pharmacy; Medical University of Sofia; 2 Dunav St.; 1000 Sofia | en_US |
| dc.description.abstract | Summary. After the social and economic changes in Eastern Europe since 1990s, substantial changes were made in the health care systems in the countries. Most of them moved from centralized Semashko to decentralized health insurance systems of Bismark type. The latter also have an impact on the pharmaceutical systems and mostly on the way of financing, pricing and reimbursement of medicines. There is no historical overview of the basic changes in the health and pharmaceutical system in Bulgaria till now that stimulated out interest towards the topic. This paper presents a historical legislation analysis of the main health care and pharmaceuticals regulatory acts. The Healthy and Safe Conditions of Labour Act, Health Act, Health Insurance Act, Medicinal Products in Human Medicine Act were analysed, as well as the main regulations endorsed in the field. The analysis focused on the main changes that influenced the future of the health care and pharmaceutical system. The reforms in the sphere of health care are radical and substantial. They lead to regulation and protection of the rights in respect of the healthcare system, the rights of the patients, the rights of the citizens in relation to medical treatments, provided by the health institutions, as well as the rights of the health specialists when providing medical help and healthcare. These acts regulate the structure, activity, organization and management of the medical and pharmaceutical areas and their financing. The regulation of the pricing and reimbursement in Bulgaria was discussed. However, this paper was produced before the recent establishment of the National Council on Pricing and Reimbursement of Medicines which is expected to make the process more transparent, controlled and visible for the general public. | en_US |
| dc.identifier.citation | M. Marcheva, L. Tosheva-Konteva and G. Petrova. Main legislative changes in healthcare system in Bulgaria during 1997-2012 - Acta medica bulgarica , 40, 2013, No 2, 48-59. | en_US |
| dc.identifier.issn | 0324-1750 | |
| dc.identifier.uri | http://hdl.handle.net/10861/717 | |
| dc.language.iso | en | en_US |
| dc.publisher | Централна медицинска библиотека - МУ София / Central Medical Library - MU Sofia | en_US |
| dc.subject | health policy, health legislation, pharmaceutical legislation | en_US |
| dc.title | Main legislative changes in healthcare system in Bulgaria during 1997-2012 | en_US |
| dc.type | Article | en_US |